Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61

References

• Masimirembwa CM, Bredberg U, Andersson TB. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges. Clin Pharmacokinet 2003;42:515–28.
   PubMed Web of Science ®Google Scholar
• Shu YZ, Johnson BM, Yang TJ. Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery. AAPS J 2008;10:178–92.
   PubMed Web of Science ®Google Scholar
• Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008;22:2454–72.
   PubMed Web of Science ®Google Scholar
• Ng JM, Curran T. The Hedgehog’s tale: developing strategies for targeting cancer. Nat Rev Cancer 2011;11:493–501.
   PubMed Web of Science ®Google Scholar
• Iovine V, Mori M, Calcaterra A, et al. One hundred faces of cyclopamine. Curr Pharm Des 2016;22:1658–81.
   PubMed Web of Science ®Google Scholar
• Infante P, Alfonsi R, Botta B, et al. Targeting GLI factors to inhibit the Hedgehog pathway. Trends Pharmacol Sci 2015;36:547–58.
   PubMed Web of Science ®Google Scholar
• Infante P, Alfonsi R, Ingallina C, et al. Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype. Cell Death Dis 2016;7:e2376.
   PubMed Web of Science ®Google Scholar
• Infante P, Mori M, Alfonsi R, et al. Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. EMBO J 2015;34:200–17.
   PubMed Web of Science ®Google Scholar
• Berman DM, Karhadkar SS, Hallahan AR, et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 2002;297:1559–61.
   PubMed Web of Science ®Google Scholar
• De Smaele E, Fragomeli C, Ferretti E, et al. An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma. Neoplasia 2008;10:89–98.
   PubMed Web of Science ®Google Scholar
• Di Magno L, Manzi D, D’Amico D, et al. Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth. Cell Cycle 2014;13:3404–13.
   PubMed Web of Science ®Google Scholar
• Ridzewski R, Rettberg D, Dittmann K, et al. Hedgehog inhibitors in rhabdomyosarcoma: a comparison of four compounds and responsiveness of four cell lines. Front Oncol 2015;5:130.
   PubMed Web of Science ®Google Scholar
• Oue T, Uehara S, Yamanaka H, et al. Hedgehog signal inhibitors suppress the invasion of human rhabdomyosarcoma cells. Pediatr Surg Int 2013;29:1153–8.
   PubMed Web of Science ®Google Scholar
• Feldmann G, Dhara S, Fendrich V, et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 2007;67:2187–96.
   PubMed Web of Science ®Google Scholar
• Varnat F, Duquet A, Malerba M, et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009;1:338–51.
   PubMed Web of Science ®Google Scholar
• Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004;431:707–12.
   PubMed Web of Science ®Google Scholar
• Watkins DN, Berman DM, Burkholder SG, et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003;422:313–17
   PubMed Web of Science ®Google Scholar
• Clement V, Sanchez P, de Tribolet N, et al. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007;17:165–172
   PubMed Web of Science ®Google Scholar
• Zhao C, Chen A, Jamieson CH, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009;458:776–9.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105–11.
   PubMed Web of Science ®Google Scholar
• Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003;3:895–902.
   PubMed Web of Science ®Google Scholar
• Coni S, Infante P, Gulino A. Control of stem cells and cancer stem cells by Hedgehog signaling: pharmacologic clues from pathway dissection. Biochem Pharmacol 2013;85:623–8.
   PubMed Web of Science ®Google Scholar
• Chen K, Huang YH, Chen JL. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin 2013;34:732–40.
   PubMed Web of Science ®Google Scholar
• Ismail F, Winkler DA. Getting to the source: selective drug targeting of cancer stem cells. ChemMedChem 2014;9:885–98.
   PubMed Web of Science ®Google Scholar
• Dlugosz A, Agrawal S, Kirkpatrick P. Vismodegib. Nat Rev Drug Discov 2012;11:437–8.
   PubMed Web of Science ®Google Scholar
• Mullard A. 2015 FDA drug approvals. Nat Rev Drug Discov 2016;15:73–6.
   PubMed Web of Science ®Google Scholar
• Ruat M, Hoch L, Faure H, Rognan D. Targeting of smoothened for therapeutic gain. Trends Pharmacol Sci 2014;35:237–46.
   PubMed Web of Science ®Google Scholar
• Rimkus TK, Carpenter RL, Qasem S, et al. Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors. Cancers (Basel) 2016;8:22.
   PubMed Web of Science ®Google Scholar
• Yauch RL, Dijkgraaf GJ, Alicke B, et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 2009;326:572–4.
   PubMed Web of Science ®Google Scholar
• Atwood SX, Sarin KY, Whitson RJ, et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell 2015;27:342–53.
   PubMed Web of Science ®Google Scholar
• Sharpe HJ, Pau G, Dijkgraaf GJ, et al. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell 2015;27:327.
   PubMed Web of Science ®Google Scholar
• Buonamici S, Williams J, Morrissey M, et al. Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med 2010;2:51ra70.
   PubMed Web of Science ®Google Scholar
• Metcalfe C, de Sauvage FJ. Hedgehog fights back: mechanisms of acquired resistance against smoothened antagonists. Cancer Res 2011;71:5057–61.
   PubMed Web of Science ®Google Scholar
• Gonnissen A, Isebaert S, Haustermans K. Targeting the Hedgehog signaling pathway in cancer: beyond smoothened. Oncotarget 2015;6:13899–913.
   PubMed Web of Science ®Google Scholar
• Lauth M, Bergström A, Shimokawa T, Toftgård R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 2007;104:8455–60.
   PubMed Web of Science ®Google Scholar
• Lauth M, Rohnalter V, Bergstrom A, et al. Correction to “Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels”. Mol Pharmacol 2011;79:793.
   Web of Science ®Google Scholar
• Lauth M, Rohnalter V, Bergström A, et al. Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels. Mol Pharmacol 2010;78:486–96.
   PubMed Web of Science ®Google Scholar
• Agyeman A, Jha BK, Mazumdar T, Houghton JA. Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding. Oncotarget 2014;5:4492–503.
   PubMed Web of Science ®Google Scholar
• Glasoe PK, Long FA. Use of glass electrodes to measure acidities in deuterium oxide. J Phys Chem 1960;64:188–90.
   Web of Science ®Google Scholar
• Pavletich NP, Pabo CO. Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science 1993;261:1701–7.
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91.
   PubMed Web of Science ®Google Scholar
• Cirigliano A, Menta S, Mori M, et al. S. cerevisiae as a tool to select inhibitors of the deneddylating activity of the COP9 signalosome. Yeast 2015;32:S175
   Web of Science ®Google Scholar
• Mori M, Dietrich U, Manetti F, Botta M. Molecular dynamics and DFT study on HIV-1 nucleocapsid protein-7 in complex with viral genome. J Chem Inf Model 2010;50:638–50.
   PubMed Web of Science ®Google Scholar
• Mori M, Massaro A, Calderone V, et al. Discovery of a new class of potent MMP inhibitors by structure-based optimization of the arylsulfonamide scaffold. ACS Med Chem Lett 2013;4:565–9.
   PubMed Web of Science ®Google Scholar
• Mori M, Moraca F, Deodato D, et al. Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor. Bioorg Med Chem Lett 2014;24:2508–11.
   PubMed Web of Science ®Google Scholar
• Baker NA, Sept D, Joseph S, et al. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 2001;98:10037–41.
   PubMed Web of Science ®Google Scholar
• Case DA, Darden TA, Cheatham TE, et al. AMBER 12. San Francisco, CA: University of California; 2012.
   Google Scholar
• Cau Y, Fiorillo A, Mori M, et al. Molecular dynamics simulations and structural analysis of Giardia duodenalis 14-3-3 protein-protein interactions. J Chem Inf Model 2015;55:2611–22.
   PubMed Web of Science ®Google Scholar
• Cau Y, Mori M, Supuran CT, Botta M. Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations. Org Biomol Chem 2016;14:8322–30.
   PubMed Web of Science ®Google Scholar
• Mori M, Nucci A, Lang MC, et al. Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity. ACS Chem Biol 2014;9:1950–5.
   PubMed Web of Science ®Google Scholar
• Sholokh M, Improta R, Mori M, et al. Tautomers of a fluorescent G surrogate and their distinct photophysics provide additional information channels. Angew Chem Int Ed Engl 2016;55:7974–8.
   PubMed Web of Science ®Google Scholar
• Mori M, Manetti F, Botta M. Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulators. J Chem Inf Model 2011;51:446–54.
   PubMed Web of Science ®Google Scholar
• Miller BR 3rd, McGee TD Jr, Swails JM, et al. MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 2012;8:3314–21.
   PubMed Web of Science ®Google Scholar
• Wang R, Lai L, Wang S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput-Aided Mol Des 2002;16:11–26.
   PubMed Web of Science ®Google Scholar
• Milletti F, Storchi L, Sforna G, Cruciani G. New and original pKa prediction method using grid molecular interaction fields. J Chem Inf Model 2007;47:2172–81.
   PubMed Web of Science ®Google Scholar
• Chenna V, Hu C, Khan SR. Synthesis and cytotoxicity studies of Hedgehog enzyme inhibitors SANT-1 and GANT-61 as anticancer agents. J Environ Sci Health A Tox Hazard Subst Environ Eng 2014;49:641–7.
   PubMed Web of Science ®Google Scholar
• Valensin D, Cau Y, Calandro P, et al. Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3sigma protein-protein interactions. Bioorg Med Chem Lett 2016;26:894–8.
   PubMed Web of Science ®Google Scholar
• Mitra A, Seaton PJ, Ali Assarpour R, Williamson T. Unprecedented concentration dependent chemical shift variation in 1H-NMR studies: a caveat in the investigations of molecular recognition and structure elucidation. Tetrahedron 1998;54:15489–98.
   Web of Science ®Google Scholar
• D’Acquarica I, Calcaterra A, Sacco F, et al. Stereochemical preference of 2′-deoxycytidine for chiral bis(diamido)-bridged basket resorcin[4]arenes. Chirality 2013;25:840–51.
   PubMed Web of Science ®Google Scholar
• Alpert AJ. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J Chromatogr 1990;499:177–96.
   PubMed Web of Science ®Google Scholar
• Hemstrom P, Irgum K. Hydrophilic interaction chromatography. J Sep Sci 2006;29:1784–821.
   PubMed Web of Science ®Google Scholar
• Nguyen HP, Schug KA. The advantages of ESI-MS detection in conjunction with HILIC mode separations: fundamentals and applications. J Sep Sci 2008;31:1465–80.
   PubMed Web of Science ®Google Scholar
• Dejaegher B, Vander Heyden Y. HILIC methods in pharmaceutical analysis. J Sep Sci 2010;33:698–715.
   PubMed Web of Science ®Google Scholar
• Lammerhofer M. HILIC and mixed-mode chromatography: the rising stars in separation science. J Sep Sci 2010;33:679–80.
   PubMed Web of Science ®Google Scholar
• Taipale J, Chen JK, Cooper MK, et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000;406:1005–9.
   PubMed Web of Science ®Google Scholar
• Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of Hedgehog signaling by direct binding of cyclopamine to smoothened. Genes Dev 2002;16:2743–8.
   PubMed Web of Science ®Google Scholar